The report “Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019” analyzes and studies the major market drivers, threats, opportunities, and challenges.
Browse 114 market data tables and 64 figures spread through 225 pages and in-depth TOC on “Cell Line Development Market”
Early buyers will receive 10% customization on this report.
This report studies the global cell line development market for the forecast period of 2014 to 2019.This market is expected to reach $3.96 billion by 2019 from$2.2 billionin 2014, and is poised to grow at a CAGR of 12.5% from 2014 to 2019.
The global cell line development market is segmented on the basis of products, type of cell lines, source of cell lines, applications, and geographies.
Based on products, the cell line development market is categorized into equipment, and media &reagents.The media and reagents segment is expected to account for a major share of the cell line development market, by product in 2014.
The media and reagents segment is further divided into serum, media, and reagents.The reagents segment is expected to account for the largest share of the cell line development market in 2014.
Talk to Our Research Analysts for More Info@
The cell line development market, by type is further segmented into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines are expected to account for a major share of the cell line development market in 2014.
On the basis of source of cell lines, the market is segmented into mammalian, insect, and amphibian. The cell lines derived from mammalian source are likely to account for the largest share of the cell line development market in 2014.
Bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery are the key application areas of cell lines. Bioproduction is expected to account for a major share among the application areas in the cell line development market.
On the basis of geography, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises of Latin America, Pacific countries, and Africa. North America holds the largest in the cell line development market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for cell line manufacturers.
Get The Sample Copy Of This Report:
Over the years, the demand for cell line development equipment and media and reagents is likely to increase owing to the increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies to develop cell lines. However, in spite of innovative technologies in the market, developing stable and authentic cell lines still remains a challenge. Increasing risk of pandemics and communicable diseases are expected to create opportunities for the development of cell lines.
Some of the major players in the global cell line development market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma-Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).
Browse related reports:
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018.
Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets